QUESTCOR PHARM (NASDAQ:QCOR)
4.28
+0.03 (0.71%)
| QUESTCOR PHARM (NASDAQ:QCOR) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $4.25 | 52 Week High | $9.81 | ||
| Open | $4.13 | 52 Week Low | $3.10 | ||
| Day High | $4.43 | P/E | 8.56 | ||
| Day Low | $4.11 | EPS | $0.50 | ||
| Volume | 359,749 | ||||
| More QCOR Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| AZN | 1 | CMLS | 1 |
| ORCD | 1 | PFE | 1 |
| ENR | 1 | SNIC | 1 |
| GMCR | 1 | BNI | 1 |
| IBCP | 1 | SNY | 1 |
| CHIP | 1 | CMLS | 1 |
Entities who have mentioned QCOR
- Stock Buyback | View Related Stories »
- Soleil Securities | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Warren Buffett | View Related Stories »
- Deutsche Bank | View Related Stories »
- Robert W Baird | View Related Stories »
- Morgan Joseph | View Related Stories »
- Standard & Poor's | View Related Stories »
- Bakken Formation | View Related Stories »
- Stanford | View Related Stories »
- After-Hours Movers | View Related Stories »
- Dividend | View Related Stories »
- Twitter | View Related Stories »
View All Major News StreetInsider.com Major News for QCOR
- Questcor Pharmaceuticals (QCOR) Misses Q3 Views
- Questcor Pharma (QCOR) Reports Q2 EPS of $0.14, Beats by 1c
- Questcor (QCOR) Misses Street's Q1 Views
View All ReportsStreetInsider.com Reports on QCOR
- Morning Movers 10/03: BNI, DDRX, BDK, AIMC, RTEC, MEDW Higher; CKEC, TPGI, IBCP, NSTC, CMLS, HEB Lower
- Questcor Pharmaceuticals (QCOR) Misses Q3 Views
- Questor Pharma (QCOR) Approves Two Key Corporate Governance Actions
- Questcor Pharmaceuticals (QCOR) Resubmits NDA for H.P. Acthar
- Morning Movers 9/21: CHIP, PER, CUR, LUNA, AEZS, NKTR Higher; DPTR, RPRX, PEIX, ATGN, QCOR, HPOL Lower
View All Press ReleasesCompany Press Releases on QCOR
- Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
- Questcor Announces Third Quarter 2009 Results
- Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms
- Questcor to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
- Questcor Issues Corrected Dial-in Numbers for November 2nd Quarterly Conference Call
StreetInsider Reports on QCOR by Category
View All BlogsBlogs on QCOR
- Best Performing Stocks Since 3/9/09 and 10/9/07
- Questcor Pharmaceuticals Q3 2009 Earnings Call Transcript
- BioMed News Bytes: Cytori, Questcor
- October FDA Calendar Stocks: Tricks or Treats?
- Questcor Pharmaceuticals: Risky, But Cheap
View All FilingsSEC Filings on QCOR
- Form 4 QUESTCOR PHARMACEUTICALS For: Nov 12 Filed by: FARRELL STEPHEN C
- Form 10-Q QUESTCOR PHARMACEUTICALS For: Sep 30
- Form 8-K QUESTCOR PHARMACEUTICALS For: Nov 02
- Form 4 Young David For: Oct 30
- Form 8-K QUESTCOR PHARMACEUTICALS For: Oct 20
Comments on QCOR
No comments are currently available.
